Expert Guidance on Personalizing Treatment of CLL: Overcoming the Conundrum of Multiple New Agents

CLL Treatment 2019 Program Image
Review emerging data from the live meeting with an on-demand Webcast and downloadable slideset to understand the optimal treatment strategy for CLL. Download a patient resource to help describe shared decision-making approaches in cancer care.
John M. Burke, MD
Nicole Lamanna, MD

Downloadable Slideset

Download these slides from our local live meeting series on CLL to review the most recent clinical data on new agents in both frontline and relapsed/refractory CLL.

John M. Burke, MD Nicole Lamanna, MD Released: June 19, 2019

CLL Resource for Patients

Download this PDF resource to give to your patients with CLL, including information on helpful web sites and questions to ask during office visits.

John M. Burke, MD Nicole Lamanna, MD Released: June 10, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Produced in collaboration with
CLL Society Logo
Supported by educational grants from
Pharmacyclics LLC, an AbbVie Company
Verastem Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?